Global Biosurgical Agent Market

The ease-of-use, high cost-effectiveness, reduced patient readmission rates, and rising physician awareness of ORC-based hemostats will continue to drive growth in the market.
Orthopedic procedures have the highest penetration rate of biosurgical agents, primarily due to the rising demand for minimally invasive surgeries. In 2023, orthopedic procedures accounted for approximately 39% of total biosurgical agent units sold, and this trend is expected to continue throughout the forecast period.
Read our Market Snapshot to access data and analysis on the state of the global biosurgical agent market from 2019 through 2033.